Treatments
Featured Article
Treating Acute Urinary Tract Infection in Postmenopausal Women
Expert perspective on management and treatment of acute urinary tract infections in postmenopausal women.
Latest News
Topical 15% Paromomycin-Aquaphilic Effective For New World Leishmaniasis
Treatment for cutaneous leishmaniasis caused by Leishmania braziliensis, using 15% paromomycin-Aquaphilic, was superior to a negative vehicle control.
Relapse-Free Cure From MDR-TB Higher Than Anticipated
The frequency of relapse-free cure from multidrug-resistant tuberculosis is higher than previously anticipated.
Similar Safety and Efficacy for Rifampin vs Isoniazid in Children, Adolescents
For children younger than 18 years, 4 months of rifampin to treat latent Mycobacterium tuberculosis had similar rates of safety and efficacy and higher rates of adherence compared with 9 months of isoniazid.
AHA Issues Scientific Statement on Managing Chagas Cardiomyopathy
The most common findings in patients with Chagas cardiomyopathy include cardiac rhythm abnormalities, myocardial abnormalities, aneurysms, and thromboembolism.
Is Short-Course Antibiotic Treatment for CAP Effective?
To investigate what impact antibiotic treatment duration has on CAP outcomes, researchers from the Warren Alpert Medical School of Brown University conducted a search of various databases for studies comparing the safety and efficacy of treatment regimens lasting ≤6 days (short) and ≥7 days (long).
FDA Strengthens Warnings for Fluoroquinolone Antibiotics
The labeling changes are based on a review of postmarketing adverse event reports found in the FDA Adverse Event Reporting System (FAERS) database and published medical literature.
FDA Approves Plazomicin for Complicated Urinary Tract Infections
Zemdri carries a Boxed Warning describing reports of nephrotoxicity, ototoxicity, and neuromuscular blockade, as well as fetal harm if administered during pregnancy.
Potential Significant Toxicity With Methotrexate, Trimethoprim-Sulfamethoxazole Combination
The case involved a 68-year-old female patient with rheumatoid arthritis on methotrexate 10mg weekly who presented to the emergency department with complaints of lethargy and weakness after being prescribed a 2-week course of TS for a bacterial skin infection.
FDA Approves New Treatment for Onchocerciasis
Moxidectin, a macrocyclic lactone, is an anthelmintic drug that selectively binds to the parasite's glutamate-gated chloride ion channels.
FDA Grant Orphan Drug Status to Brincidofovir for Smallpox
Brincidofovir is the Company's lead candidate, a nucleotide analog that has antiviral activity against variola virus, which causes smallpox.
Sign Up for Free e-newsletters
Infectious Disease Advisor Articles
- Dundee Severity Classification Improves Management of Patients With Cellulitis
- Three New Ebola Vaccines Demonstrate Persistent Immune Response
- Best Approach to Reduce Surgical Site Infections Before Colorectal Surgery
- Tap Water in Neti Pot Linked to Death From Brain-Eating Amoeba
- Updated Recommendations, Hepatitis A Vaccine Postexposure Prophylaxis and Travel
- Best Approach to Reduce Surgical Site Infections Before Colorectal Surgery
- HIV Seroconversion Despite PrEP Therapy
- Management of Mycobacterium chimaera Outbreak From Heater-Cooler Units
- Novel H pylori Eradication Therapy Effective in Phase 3 Trial
- Topical 15% Paromomycin-Aquaphilic Effective For New World Leishmaniasis
- New Study: High HCV Re-Infection Rates in People Who Inject Drugs
- Early Diagnosis of HIV Linked With Higher Viral Loads Than Later Diagnosis
- Bacterial Vaginosis Treatment Does Not Reduce Late Miscarriages, Preterm Birth
- In Vivo Activity of Cefiderocol Against Resistant Gram-Negative Bacteria
- Procalcitonin-Guided Antibiotic Treatment Lowered Antibiotic Exposure
